Frontiers in Pharmacology (Apr 2022)

Corrigendum: Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance

  • Xixi Lin,
  • Yongliang Jia,
  • Yongliang Jia,
  • Xinwei Dong,
  • Xinwei Dong,
  • Jian Shen,
  • Jian Shen,
  • Yachao Jin,
  • Yanyou Li,
  • Fang Wang,
  • Eitan Anenberg,
  • Jiancang Zhou,
  • Jianping Zhu,
  • Xiaoping Chen,
  • Qiangmin Xie,
  • Qiangmin Xie,
  • Yicheng Xie

DOI
https://doi.org/10.3389/fphar.2022.890886
Journal volume & issue
Vol. 13

Abstract

Read online

No abstracts available.

Keywords